Annual CFF
$3.54 M
-$428.25 M-99.18%
December 31, 2023
Summary
- As of February 12, 2025, AMLX annual cash flow from financing activities is $3.54 million, with the most recent change of -$428.25 million (-99.18%) on December 31, 2023.
- During the last 3 years, AMLX annual CFF has fallen by -$43.28 million (-92.43%).
- AMLX annual CFF is now -99.18% below its all-time high of $431.79 million, reached on December 31, 2022.
Performance
AMLX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$80.00 K
+$53.00 K+196.30%
September 30, 2024
Summary
- As of February 12, 2025, AMLX quarterly cash flow from financing activities is $80.00 thousand, with the most recent change of +$53.00 thousand (+196.30%) on September 30, 2024.
- Over the past year, AMLX quarterly CFF has dropped by -$809.00 thousand (-91.00%).
- AMLX quarterly CFF is now -99.97% below its all-time high of $232.16 million, reached on December 31, 2022.
Performance
AMLX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$468.00 K
-$809.00 K-63.35%
September 30, 2024
Summary
- As of February 12, 2025, AMLX TTM cash flow from financing activities is $468.00 thousand, with the most recent change of -$809.00 thousand (-63.35%) on September 30, 2024.
- Over the past year, AMLX TTM CFF has dropped by -$235.01 million (-99.80%).
- AMLX TTM CFF is now -99.89% below its all-time high of $431.79 million, reached on December 31, 2022.
Performance
AMLX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMLX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.2% | -91.0% | -99.8% |
| 3 y3 years | -92.4% | -91.0% | -99.8% |
| 5 y5 years | +430.4% | -91.0% | -99.8% |
AMLX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.2% | at low | -100.0% | +107.5% | -99.9% | at low |
| 5 y | 5-year | -99.2% | +430.4% | -100.0% | +107.5% | -99.9% | at low |
| alltime | all time | -99.2% | +430.4% | -100.0% | +107.5% | -99.9% | at low |
Amylyx Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $80.00 K(+196.3%) | $468.00 K(-63.4%) |
| Jun 2024 | - | $27.00 K(-79.4%) | $1.28 M(-51.5%) |
| Mar 2024 | - | $131.00 K(-43.0%) | $2.63 M(-25.7%) |
| Dec 2023 | $3.54 M(-99.2%) | $230.00 K(-74.1%) | $3.54 M(-98.5%) |
| Sep 2023 | - | $889.00 K(-35.8%) | $235.47 M(+0.4%) |
| Jun 2023 | - | $1.38 M(+33.1%) | $234.59 M(+1.0%) |
| Mar 2023 | - | $1.04 M(-99.6%) | $232.37 M(-46.2%) |
| Dec 2022 | $431.79 M | $232.16 M(>+9900.0%) | $431.79 M(+117.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $0.00(-100.0%) | $198.56 M(-39.9%) |
| Jun 2022 | - | -$828.00 K(-100.4%) | $330.21 M(-0.8%) |
| Mar 2022 | - | $200.46 M(<-9900.0%) | $333.03 M(+110.1%) |
| Dec 2021 | $158.51 M(+238.5%) | -$1.06 M(-100.8%) | $158.51 M(-0.7%) |
| Sep 2021 | - | $131.65 M(+6505.7%) | $159.57 M(+471.5%) |
| Jun 2021 | - | $1.99 M(-92.3%) | $27.92 M(+7.7%) |
| Mar 2021 | - | $25.93 M | $25.93 M |
| Dec 2020 | $46.82 M(+6909.4%) | - | - |
| Dec 2019 | $668.00 K | - | - |
FAQ
- What is Amylyx Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual CFF year-on-year change?
- What is Amylyx Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly CFF year-on-year change?
- What is Amylyx Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals TTM CFF year-on-year change?
What is Amylyx Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of AMLX is $3.54 M
What is the all time high annual CFF for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual cash flow from financing activities is $431.79 M
What is Amylyx Pharmaceuticals annual CFF year-on-year change?
Over the past year, AMLX annual cash flow from financing activities has changed by -$428.25 M (-99.18%)
What is Amylyx Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of AMLX is $80.00 K
What is the all time high quarterly CFF for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly cash flow from financing activities is $232.16 M
What is Amylyx Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, AMLX quarterly cash flow from financing activities has changed by -$809.00 K (-91.00%)
What is Amylyx Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of AMLX is $468.00 K
What is the all time high TTM CFF for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high TTM cash flow from financing activities is $431.79 M
What is Amylyx Pharmaceuticals TTM CFF year-on-year change?
Over the past year, AMLX TTM cash flow from financing activities has changed by -$235.01 M (-99.80%)